Skip to main content

Advertisement

SpringerLink
Log in

Angioedema Phenotypes: Disease Expression and Classification

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Due to marked heterogeneity of clinical presentations, comprehensive knowledge of angioedema phenotypes is crucial for correct diagnosis and choosing the appropriate therapeutic approach. One of the ways to a meaningful clinical distinction can be made between forms of angioedema occurring “with or without wheals.” Angioedema with wheals (rash) is a hallmark of urticaria, either acute or chronic, spontaneous or inducible. Angioedema without wheals may still be manifested in about 10 % of patients with urticaria, but it may also occur as a separate entity. Several classifications of angioedema as part of urticaria were published over time, while a latest one, released in 2014 (HAWK group consensus, see below), provided a classification of all forms of “angioedema without wheals” distinct from urticaria, which will be the focus of the present review. At this time, the HAWK consensus classification is the best in terms of covering the pathophysiology, mediators involved, angioedema triggers, and clinical expression. According to this classification, three types of hereditary angioedema (genetic C1-INH deficiency, normal C1-INH with factor XII mutations, and unknown origin) and four types of acquired angioedema (C1-INH deficiency, related to ACE inhibitors intake, idiopathic histaminergic, and idiopathic non-histaminergic) are presented. We will review the distinctive clinical features of each phenotype in details.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT (2010) The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407–14

    Article  PubMed  Google Scholar 

  2. Quincke H (1882) Uber akutes umschriebened hautodem. Monatshe Prakt Dermatol 1:129–131

    Google Scholar 

  3. Osler W (1888) Hereditary angio-neurotic oedema. Am J Med Sci 95:362–367

    Article  Google Scholar 

  4. Vestergaard C, Deleuran M (2015) Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy. Ther Adv Chronic Dis 6:304–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW et al (2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–87

    Article  CAS  PubMed  Google Scholar 

  6. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602–16

    Article  CAS  PubMed  Google Scholar 

  7. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(Suppl 1):S145–56

    Article  CAS  PubMed  Google Scholar 

  8. Nussberger J, Cugno M, Cicardi M (2002) Bradykinin-mediated angioedema. N Engl J Med 347:621–2

    Article  PubMed  Google Scholar 

  9. Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3:311–7

    Article  CAS  PubMed  Google Scholar 

  10. Defendi F, Charignon D, Ghannam A, Baroso R, Csopaki F, Allegret-Cadet M et al (2013) Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One 8, e70140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A (1999) Idiopathic nonhistaminergic angioedema. Am J Med 106:650–4

    Article  CAS  PubMed  Google Scholar 

  12. Du-Thanh A, Raison-Peyron N, Drouet C, Guillot B (2010) Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 65:793–5

    Article  CAS  PubMed  Google Scholar 

  13. Del Corso I, Puxeddu I, Sardano E, Geraci S, Breggia M, Rocchi V et al (2012) Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Ann Allergy Asthma Immunol 108:460–1

    Article  PubMed  Google Scholar 

  14. Colas C, Montoiro R, Fraj J, Garces M, Cubero JL, Caballero T (2012) Nonhistaminergic idiopathic angioedema: clinical response to icatibant. J Investig Allergol Clin Immunol 22:520–1

    CAS  PubMed  Google Scholar 

  15. Montinaro V, Loizzo G, Zito A, Castellano G, Gesualdo L (2013) Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema. Am J Emerg Med 31(8):1295.e5–6. doi:10.1016/j.ajem.2013.04.024

    Article  Google Scholar 

  16. Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK et al (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56:278–82

    Article  PubMed  Google Scholar 

  17. Bova M, Guilarte M, Sala-Cunill A, Borrelli P, Rizzelli GM, Zanichelli A (2015) Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med 10:345–50

    Article  PubMed  Google Scholar 

  18. Bas M, Greve J, Stelter K, Havel M, Strassen U, Rotter N et al (2015) A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med 372:418–25

    Article  PubMed  Google Scholar 

  19. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330–5

    Article  PubMed  Google Scholar 

  20. Lopez-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, Lopez-Trascasa M (2010) A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol 126:1307–10 e3

    Article  CAS  PubMed  Google Scholar 

  21. Bafunno V, Divella C, Sessa F, Tiscia GL, Castellano G, Gesualdo L et al (2013) De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy Clin Immunol 132(3):748–750.e3. doi:10.1016/j.jaci.2013.04.006

    Article  CAS  PubMed  Google Scholar 

  22. Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A et al (2000) Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147–54

    Article  CAS  PubMed  Google Scholar 

  23. Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M et al (2015) A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis 10:11

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267–74

    Article  PubMed  Google Scholar 

  25. Bors A, Csuka D, Varga L, Farkas H, Tordai A, Fust G et al (2013) Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations. J Allergy Clin Immunol 131(6):1708–11. doi:10.1016/j.jaci.2012.11.015

    Article  CAS  PubMed  Google Scholar 

  26. Xu YY, Zhi YX, Yin J, Wang LL, Wen LP, Gu JQ et al (2012) Mutational spectrum and geno-phenotype correlation in Chinese families with hereditary angioedema. Allergy 67:1430–6

    Article  CAS  PubMed  Google Scholar 

  27. Bygum A, Fagerberg CR, Ponard D, Monnier N, Lunardi J, Drouet C (2011) Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76–84

    Article  CAS  PubMed  Google Scholar 

  28. Lopez-Lera A, Cabo FS, Garrido S, Dopazo A, Lopez-Trascasa M (2013) Disease-modifying factors in hereditary angioedema: an RNA expression-based screening. Orphanet J Rare Dis 8:77

    Article  PubMed  PubMed Central  Google Scholar 

  29. Speletas M, Szilagyi A, Psarros F, Moldovan D, Magerl M, Kompoti M et al (2015) Hereditary angioedema: molecular and clinical differences among European populations. J Allergy Clin Immunol 135:570–3

    Article  PubMed  Google Scholar 

  30. Andrejevic S, Korosec P, Silar M, Kosnik M, Mijanovic R, Bonaci-Nikolic B et al (2015) Hereditary angioedema due to C1 inhibitor deficiency in Serbia: two novel mutations and evidence of genotype-phenotype association. PLoS One 10, e0142174

    Article  PubMed  PubMed Central  Google Scholar 

  31. Martinez‐Saguer I, Gutowski Z, Andritschke K, Csuka D, Kőhalmi KV, Varga L, Farkas H (2015) Inter individual variations in symptom expression and clinical course in monozygotic twins with hereditary angioedema type I. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 55

  32. Leibovich I, Golander H, Somech R, Reshef A (2015) The relationship between premonitory signs and symptoms (“prodromes”) and the onset of hereditary angioedema attacks. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 61

  33. Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M (2014) High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy 44:1503–14

    Article  CAS  PubMed  Google Scholar 

  34. Grumach AS, Veronez CL, Cagini N, Stieber C, Nicolicht P, Constantino‐Silva RN, Gonçalves RF, Cordeiro E, Komninakis S, Cichon S, Pesquero JB (2015) Hereditary angioedema without c1 inhibitor deficiency: evaluation of 21 families. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 63

  35. Bork K, Wulff K, Witzke G, Hardt J (2015) Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Allergy 70(8):1004–12. doi:10.1111/all.12648

    Article  CAS  PubMed  Google Scholar 

  36. Zingale LC, Castelli R, Zanichelli A, Cicardi M (2006) Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin N Am 26(4):669–90

    Article  Google Scholar 

  37. Cicardi M, Zanichelli A (2010) The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. Curr Mol Med 10:354–60

    Article  CAS  PubMed  Google Scholar 

  38. Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C (2003) Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med 115:420–1

    Article  PubMed  Google Scholar 

  39. Schreiber AD, Zweiman B, Atkins P, Goldwein F, Pietra G, Atkinson B et al (1976) Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood 48:567–80

    CAS  PubMed  Google Scholar 

  40. Jackson J, Sim RB, Whelan A, Feighery C (1986) An IgG autoantibody which inactivates C1-inhibitor. Nature 323:722–4

    Article  CAS  PubMed  Google Scholar 

  41. Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M (2007) Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 92:716–8

    Article  PubMed  Google Scholar 

  42. Wu MA, Castelli R (2016) The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med 54:207–14

    CAS  PubMed  Google Scholar 

  43. Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D et al (2016) High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol. doi:10.1111/bjh.13908

    Google Scholar 

  44. Alsenz J, Lambris JD, Bork K, Loos M (1989) Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients’ C1-INH and anti-C1-INH autoantibodies. J Clin Invest 83:1794–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Burkhart DG, Brown NJ, Griffin MR, Ray WA, Hammerstrom T, Weiss S (1996) Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiol Drug Saf 5:149–54

    Article  CAS  PubMed  Google Scholar 

  46. Brown NJ, Ray WA, Snowden M, Griffin MR (1996) Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60:8–13

    Article  CAS  PubMed  Google Scholar 

  47. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J et al (2005) Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165:1637–42

    Article  CAS  PubMed  Google Scholar 

  48. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624–30

    Article  CAS  PubMed  Google Scholar 

  49. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS et al (2012) Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383–91

    Article  CAS  PubMed  Google Scholar 

  50. Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J (1999) Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 44:21–5

    Article  CAS  PubMed  Google Scholar 

  51. Campo P, Fernandez TD, Canto G, Mayorga C (2013) Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol 13:337–44

    Article  CAS  PubMed  Google Scholar 

  52. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273–7

    Article  CAS  PubMed  Google Scholar 

  53. Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH et al (1988) Clinical profile of angioedema associated with angiotensin converting- enzyme inhibition. JAMA 260:967–70

    Article  CAS  PubMed  Google Scholar 

  54. Dean DE, Schultz DL, Powers RH (2001) Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 46:1239–43

    Article  CAS  PubMed  Google Scholar 

  55. Dobbels P, Van Overbeke L, Vanbeckevoort D, Hiele M (2009) Acute abdomen due to intestinal angioedema induced by ACE inhibitors: not so rare? Acta Gastroenterol Belg 72:455–7

    CAS  PubMed  Google Scholar 

  56. Benson BC, Smith C, Laczek JT (2013) Angiotensin converting enzyme inhibitor-induced gastrointestinal angioedema: a case series and literature review. J Clin Gastroenterol 47(10):844–9. doi:10.1097/MCG.0b013e318299c69d

    Article  CAS  PubMed  Google Scholar 

  57. Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R et al (2015) Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med 277:585–93

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, Luigi Sacco Hospital, Milan, Italy

    Maddalena Alessandra Wu, Francesca Perego, Andrea Zanichelli & Marco Cicardi

Authors
  1. Maddalena Alessandra Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Perego
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Zanichelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Cicardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Cicardi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, M.A., Perego, F., Zanichelli, A. et al. Angioedema Phenotypes: Disease Expression and Classification. Clinic Rev Allerg Immunol 51, 162–169 (2016). https://doi.org/10.1007/s12016-016-8541-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-016-8541-z

Keywords

Search

Navigation